Enabling the Future of Subcutaneous Biologics: SCHOTT Pharma’s Large Volume Platform

Enabling the Future of Subcutaneous Biologics: SCHOTT Pharma’s Large Volume Platform

Wednesday, January 21, 2026 11:55 AM to 12:25 PM · 30 min. (Africa/Abidjan)
Sustainability Theatre - 4J78
Sustainability Conference
Sustainability

Information

SCHOTT Pharma is enabling the shift to large-volume subcutaneous injections with innovative glass containers in the 5ml format, expanding patient-centric care and supporting advanced biologics delivery. Their broad portfolio and platform solutions accelerate time to market, ensure compatibility with devices, and redefine convenience for both patients and pharmaceutical partners in large volume injections

Log in

See all the content and easy-to-use features by logging in or registering!